TGHSA
EPRS

TPG Group Holdings (SBS) Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,223,922
Closed -$44K – 70
2016
Q3 		$44K Hold
2,223,922
– – ﹤0.01% 54
2016
Q2 		$1M Hold
2,223,922
– – 0.01% 55
2016
Q1 		$5.98M Hold
2,223,922
– – 0.06% 45
2015
Q4 		$6.87M Hold
2,223,922
– – 0.05% 42
2015
Q3 		$9.83M Hold
2,223,922
– – 0.05% 40
2015
Q2 		$12.7M Hold
2,223,922
– – 0.06% 37
2015
Q1 		$19.9M Hold
2,223,922
– – 0.1% 29
2014
Q4 		$12.6M Hold
2,223,922
– – 0.08% 31
2014
Q3 		$16M Buy
+2,223,922
New +$19.2M 0.11% 24

TPG Group Holdings (SBS) Advisors's EPRS Position: Q4 2016 in Review

TPG Group Holdings (SBS) Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q4 2016, closing a stake of 2,223,922 shares — an estimated $44K sold.

TPG Group Holdings (SBS) Advisors first reported a position in EPRS in Q3 2014 and held it in 9 quarters. The position peaked at $19.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds EPRS as of Q4 2016.

  • TPG Group Holdings (SBS) Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q4 2016 after selling out during the quarter.
  • TPG Group Holdings (SBS) Advisors sold 2,223,922 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q4 2016, an estimated $44K.
  • TPG Group Holdings (SBS) Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 9 quarters.
  • TPG Group Holdings (SBS) Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $19.9M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q4 2016.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.